Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac sodium suppository versus oxycodone for catheter-related bladder discomfort during PACU recovery
ChiCTR2400087239Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of diclofenac and oxycodone in cystitis (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoint: Decrease in CRBD severity score from baseline. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
diclofenacoxycodone
03
Conditions
cystitis
Beyond the preview
Go deeper on ChiCTR2400087239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087239.